| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Berger Dietmar | Chief Medical Officer | 333 LAKESIDE DR., FOSTER CITY | /s/ Amy Kim by Power of Attorney for Dietmar Berger | 12 Mar 2026 | 0001739515 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Common Stock | Options Exercise | +2,133 | +12% | 20,045 | 10 Mar 2026 | Direct | F1 | ||
| transaction | GILD | Common Stock | Tax liability | -1,063 | -5.3% | $148.56* | 18,982 | 10 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Restricted Stock Unit | Options Exercise | -2,133 | -5.2% | 39,046 | 10 Mar 2026 | Common Stock | 2,133 | Direct | F1, F2 | |||
| transaction | GILD | Restricted Stock Unit | Award | +8,415 | +22% | 47,461 | 10 Mar 2026 | Common Stock | 8,415 | Direct | F1, F2 | |||
| transaction | GILD | Non-qualified Stock Option (Right to Buy) | Award | +31,475 | $0.000000* | 31,475 | 10 Mar 2026 | Common Stock | 31,475 | $148.56 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| F2 | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. |
| F3 | The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |